Thermo Fisher Scientific TMO
NYSE TMO
$688.94 -3.89 (-0.56%)
At close: Nov 19, 2026 · 4:00 PM EST

Thermo Fisher Scientific (TMO) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Thermo Fisher Scientific (TMO) posted Liabilities and Shareholders Equity of $114.23 billion for Q3 2026, up 10.9% from $103.02 billion a year earlier and up 0.9% from the prior quarter.

Analysis

Thermo Fisher Scientific (TMO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Thermo Fisher Scientific's Liabilities and Shareholders Equity came in at $110.34 billion, up 13.4% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • In prior years, Thermo Fisher Scientific's Liabilities and Shareholders Equity was $97.32 billion in FY2024 (-1.4%), $98.73 billion in FY2023 (+1.6%), $97.15 billion in FY2022 (+2.1%) and $95.12 billion in FY2021 (+37.8%).
  • The Q3 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q2 2009.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last seven quarters, with growth averaging 7.1% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2022, with growth of 40.7%; the weakest was Q4 2024, with a decline of 1.4%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $113.17 billion (Q2 2026), $113.28 billion (Q1 2026) and $110.34 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn 114.23 Bn
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn 108.25 Bn
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn 93.28 Bn
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn 19.35 Bn
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn 93.31 Bn
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn 47.25 Bn
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn 45.46 Bn
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn 14.14 Bn
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 13.97 Bn
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn 2.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 26, 2026 114.23 Bn
Jun 27, 2026 113.17 Bn
Mar 28, 2026 113.28 Bn
Dec 31, 2025 110.34 Bn
Sep 27, 2025 103.02 Bn
Jun 28, 2025 101.23 Bn
Mar 29, 2025 99.04 Bn
Dec 31, 2024 97.32 Bn
Sep 28, 2024 100.36 Bn
Jun 29, 2024 98.50 Bn
Mar 30, 2024 97.10 Bn
Dec 31, 2023 98.73 Bn
Sep 30, 2023 97.06 Bn
Jul 1, 2023 94.11 Bn
Apr 1, 2023 94.66 Bn
Dec 31, 2022 97.15 Bn
Oct 1, 2022 90.54 Bn
Jul 2, 2022 90.58 Bn
Apr 2, 2022 92.75 Bn
Dec 31, 2021 95.12 Bn
API Access

Thermo Fisher Scientific Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TMO&period=max&api_key=YOUR_API_KEY